|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$889,639
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$78,180
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
SPORE in Lymphoma
|
3P50CA126752-03S1
|
$371,941
|
$111,582
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-03
|
$2,266,618
|
$679,985
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-04
|
$134,015
|
$134,015
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Localization and Function of iNKT Cells in Neuroblastoma
|
7R01CA116548-05
|
$229,963
|
$229,963
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$18,765
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$39,296
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$242,400
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
3K12CA090433-08S1
|
$77,845
|
$77,845
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Research Training Program
|
3T32CA115303-04S1
|
$64,999
|
$64,999
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-08
|
$750,727
|
$750,727
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Research Training Program
|
5T32CA115303-04
|
$377,169
|
$377,169
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
1R01CA132899-01A1
|
$403,685
|
$403,685
|
RIS, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
7R01CA112182-05
|
$506,986
|
$506,986
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-02
|
$318,513
|
$318,513
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Study of Valproic Acid in Pediatric Brain Tumors
|
5K23CA113721-04
|
$135,036
|
$135,036
|
SU, JACK
|
BAYLOR COLLEGE OF MEDICINE
|
|
DF/HCC Kidney Cancer SPORE
|
2P50CA101942-06A1
|
$2,300,000
|
$276,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Early Infant Feeding and Epigenetic Modification in Tumor Suppressor Genes
|
1R03CA139406-01A1
|
$83,648
|
$83,648
|
Merewood, Anne
|
BOSTON MEDICAL CENTER
|
|
Oncogenic NOTCH Signaling
|
5P01CA119070-04
|
$1,012,243
|
$415,020
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of NUT-Rearranged Carcinoma
|
5R01CA124633-03
|
$299,250
|
$299,250
|
French, Christopher
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-22
|
$560,086
|
$280,043
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-09
|
$725,501
|
$725,501
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-14
|
$417,501
|
$41,750
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Targeting MLL As Anticancer Therapy for Infant Acute Lymphoblastic Leukemia
|
1R43CA141903-01
|
$130,694
|
$130,694
|
Burkhart, Catherine
|
BUFFALO BIOLABS, LLC
|
|
Safety/Efficacy of Liposomal Reversan, a novel MRP1 modulator for Cancer Therapy
|
1R41CA137977-01
|
$104,608
|
$34,521
|
Sen, Arindam
|
BUFFALO BIOLABS, LLC
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$4,212
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$5,993
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$291,927
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Outcomes of Curable Cancers in Vulnerable Populations
|
5R03CA136064-02
|
$54,950
|
$13,738
|
Koroukian, Siran
|
CASE WESTERN RESERVE UNIVERSITY
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
5R01CA134051-02
|
$493,967
|
$493,967
|
MOORMANN, ANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-05
|
$318,664
|
$159,332
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-07
|
$369,046
|
$184,523
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-02
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Investigating the Role of Adipocytes on Leukemia Relapse
|
1R01CA139060-01A1
|
$347,623
|
$347,623
|
Mittelman, Steven
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
1R01CA139032-01
|
$332,000
|
$166,000
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-10
|
$1,950,665
|
$1,950,665
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-16
|
$421,986
|
$421,986
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-05
|
$1,731,711
|
$1,731,711
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Oncolytic HSV Therapy in Immunocompetent Sarcoma Models
|
5R01CA114004-04
|
$258,529
|
$258,529
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Virotherapy for Neuroblastoma Stem Cells
|
5R21CA133663-02
|
$202,500
|
$202,500
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-03
|
$90,274
|
$90,274
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Empirical Likelihood Bayes Analysis of Quantile Regression Model
|
1R03CA133944-01A2
|
$83,120
|
$41,560
|
Kim, Mi-Ok
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Pathogenesis of MLL-Fusion Gene Leukemia
|
7K08CA122191-03
|
$135,270
|
$135,270
|
Kumar, Ashish
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
The Ron Receptor Tyrosine Kinase in Hepatic Tumorigenesis
|
5K08CA111819-04
|
$132,840
|
$66,420
|
LEONIS, MIKE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Targeting Oncolytic HSV to Neuroblastoma & Malig. Peripheral Nerve Sheath Tumors
|
5F31CA132613-02
|
$32,933
|
$32,933
|
Maldonado, Arturo
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Rac GTPases as Targets in Lymphomagenesis
|
5R01CA125658-03
|
$285,000
|
$142,500
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-05
|
$256,197
|
$256,197
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
|
5K08CA123100-04
|
$139,320
|
$139,320
|
ATTIYEH, EDWARD
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-05
|
$119,402
|
$119,402
|
BAGATELL, ROCHELLE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
Total relevant funding to Childhood Cancers for this search: $192,844,826
|